Doctors complain to Columbia about Dr. Oz

Lee Goldman, M.D.
Dean of the Faculties of Health Sciences and Medicine
Columbia University

Dear Dr. Goldman:

I am writing to you on behalf of myself and the undersigned colleagues below, all of whom are distinguished physicians.  Read more »

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer, MD

Review: The Blackberry Passport works well as a mini laptop in your pocket

April 10, 2015- By Steven E. Greer, MD

I have been testing the new Blackberry Passport smartphone for the last month. Actually, it is more than a smartphone. Read more »

Tiger Woods’ career ended after he bulked up

April 10, 2015- By Steven E. Greer, MD

Ten years ago, Tiger Woods hit one of the most memorable shots in golf when he chipped in a birdie on the 16th hole at Augusta in the Read more »

Interview with the CEO of Neovasc, Alexei Marko

How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD

Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the New England Compounding Pharmacy made the news in 2012. The facility was filthy, unregulated, and Read more »

The PCSK9 LDL drugs do not cut heart risk in half

March 18, 2015- Op-Ed by Steven E. Greer, MD

The American College of Cardiology (ACC) meeting is underway, and the main Late Breaking data making the national news came from the PCSK9-antibody drugs (evolocumab and alirocumab) that dramatically Read more »

How to establish a face transplant team

March 3, 2015- Interviewed by Steven E. Greer, MD

In Part 2 of our interview with Eduardo Rodriguez, MD, DDS, Chairman of Plastic Surgery at NYU, he discusses the new face transplant team that he has assembled, preparing for their first case.

Vagal nerve stimulation for weight loss

January 22, 2015- Interviewed by Steven E. Greer, MD

Erik Dutson, MD, bariatric surgeon from UCLA, Read more »

Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.

October 23, 2013- Interviewed by Steven E. Greer, MD

The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer. Topics discussed include the latest clinical trial data on inhaled insulin Afrezza and the cash situation. We also discuss Mr. Mann’s other company, Second Sight, which has a Medicare and FDA-approved bionic eye to treat diseases that damage the nerves in the retina.

Super rapid acting insulin and inhaled insulin

WordPress Themes